Drug trial for brain fog after COVID-19
Part of Infections, Lungs & breathing clinical trials.
This Phase 2 trial tests DAOIB to improve “brain fog” and thinking problems that happen after COVID-19. You may be screened if your symptoms started after a COVID infection and have lasted for months, and if your health tests are normal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have brain fog or thinking problems after COVID that lasted at least 2 months and started after your COVID infection (ongoing for at least 3 months total).
- You do not have another medical condition that better explains your symptoms.
- Your blood and urine tests, and heart tracing (ECG), are all within normal limits.
- You have no major stroke or circulation problems in the brain (significant cerebrovascular disease).
- You have not taken memantine recently or at all (a specific brain medicine).
- You can follow study instructions and complete tests; no current severe hallucinations, confusion, or delirium.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a non-invasive treatment to help with brain fog caused by long COVID. It may improve your symptoms if you have trouble thinking clearly or focusing.
This trial studies if brain scans can help understand 'brain fog' in Long COVID. It also looks at how a gentle magnetic stimulation might affect symptoms. If you have ongoing thinking problems after COVID, this study may help find new ways to help.
This trial tests if hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) helps with long COVID symptoms, especially brain fog and thinking problems. It may be an option if you have had lingering symptoms for at least 2 months and can travel to one of the study sites.
This trial tests whether acupuncture can help improve memory, focus, and other thinking problems that some people have after COVID-19. It also looks at how acupuncture might affect brain networks.
This study tests a computer-based cognitive training program combined with a gentle nerve stimulation device to see if it can improve brain fog and daily functioning in people with long COVID. If you're struggling with thinking, memory, or concentration after COVID, this might help.
This trial tests a gentle brain stimulation technique (transcranial direct current stimulation) to see if it can ease long COVID symptoms like brain fog and fatigue. You will receive either the real stimulation or a sham (inactive) treatment to compare effects.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.